RenovarO Inc. Files 8-K on Material Agreement & Equity Sales
Ticker: LNAI · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1527728
| Field | Detail |
|---|---|
| Company | Renovaro Inc. (LNAI) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
TL;DR
RenovarO Inc. (formerly Enochian) filed an 8-K on 7/9/25 covering a material agreement and equity sales.
AI Summary
On July 9, 2025, RenovarO Inc. filed an 8-K detailing a material definitive agreement and unregistered sales of equity securities. The filing also included Regulation FD disclosures and financial statements. The company, formerly known as Enochian Biosciences Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This 8-K filing indicates significant corporate activity, including a new material agreement and equity transactions, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered equity sales, which can introduce financial and operational risks.
Key Numbers
- 001-38758 — SEC File Number (Identifies the company's filing with the SEC)
- 45-2259340 — EIN (Employer Identification Number for the company)
Key Players & Entities
- RENOVARO INC. (company) — Registrant
- Enochian Biosciences Inc. (company) — Former company name
- July 9, 2025 (date) — Date of earliest event reported
- July 8, 2025 (date) — Date as of change
FAQ
What is the nature of the material definitive agreement mentioned in the filing?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What type of equity securities were sold in the unregistered sales?
The filing mentions unregistered sales of equity securities, but the specific type and details of these securities are not detailed in the provided text.
What is the primary business of RenovarO Inc.?
RenovarO Inc. is in the Pharmaceutical Preparations sector, with SIC code 2834.
When did RenovarO Inc. change its name from Enochian Biosciences Inc.?
The company formerly known as Enochian Biosciences Inc. changed its name on August 4, 2023.
What are the key items reported in this 8-K filing?
This 8-K filing reports on the entry into a material definitive agreement, unregistered sales of equity securities, Regulation FD disclosure, and financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 regarding RENOVARO INC. (LNAI).